Estrogens and the risk of complex regional pain syndrome (CRPS)

Objective Since complex regional pain syndrome (CRPS) shows a clear female predominance, we investigated the association between the cumulative as well as current exposure to estrogens, and CRPS. Methods A population‐based case–control study was conducted in the Integrated Primary Care Information (...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacoepidemiology and drug safety 2009-01, Vol.18 (1), p.44-52
Main Authors: de Mos, M., Huygen, F. J. P. M., Stricker, B. H. Ch, Dieleman, J. P., Sturkenboom, M.C. J. M.
Format: Article
Language:English
Subjects:
Adult
Age of Onset
Aged
Case-Control Studies
complex regional pain syndrome
Complex Regional Pain Syndromes - epidemiology
Complex Regional Pain Syndromes - etiology
Contraceptives, Oral - adverse effects
estrogen
Estrogen Replacement Therapy - adverse effects
Estrogens - administration & dosage
Estrogens - adverse effects
Estrogens - metabolism
Female
hormones
Humans
Lactation - metabolism
Menarche - metabolism
Menopause - metabolism
Middle Aged
Netherlands - epidemiology
Pregnancy
Risk Factors
Sex Factors
Surveys and Questionnaires
Time Factors
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective Since complex regional pain syndrome (CRPS) shows a clear female predominance, we investigated the association between the cumulative as well as current exposure to estrogens, and CRPS. Methods A population‐based case–control study was conducted in the Integrated Primary Care Information (IPCI) project in the Netherlands. Cases were identified from electronic records (1996–2005) and included if they were confirmed during a visit (using International Association for the Study of Pain Criteria), or had been diagnosed by a specialist. Controls were matched to cases on gender, age, calendar time, and injury. Measures of cumulative endogenous estrogen exposure were obtained by questionnaire and included age of menarche and menopause, menstrual life, and cumulative months of pregnancy and breast‐feeding. Current estrogen exposure at CRPS onset was retrieved from the electronic medical records and determined by current pregnancy or by the use of oral contraceptive (OC) drugs or hormonal replacement therapy (HRT). Results Hundred and forty‐three female cases (1493 controls) were included in analyses on drug use and pregnancies, while cumulative endogenous estrogen exposure was studied in 53 cases (58 controls) for whom questionnaire data were available. There was no association between CRPS and either cumulative endogenous estrogen exposure, OC, or HRT use. CRPS onset was increased during the first 6 months after pregnancy (OR: 5.6, 95%CI: 1.0–32.4), although based on small numbers. Discussion We did not find an association between CRPS onset and cumulative endogenous estrogen exposure or current OC or HRT use, but more powered studies are needed to exclude potential minor associations. Copyright © 2008 John Wiley & Sons, Ltd.
ISSN:1053-8569
1099-1557
DOI:10.1002/pds.1683